Trevi Therapeutics, Inc. TRVI Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s operating cash flow?
- Trevi Therapeutics, Inc. (TRVI) reported operating cash flow of -$16.69M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s operating cash flow changed year-over-year?
- Trevi Therapeutics, Inc.'s operating cash flow decreased by 23.8% year-over-year, from -$13.48M to -$16.69M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Trevi Therapeutics, Inc.'s operating cash flow has grown at a 9.8% compound annual growth rate (CAGR), from -$28.95M to -$42.09M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.